BACKGROUND: Understanding the epidemiology of moderate-to-severe psoriasis is essential for its management. OBJECTIVE: To assess the epidemiological characteristics of patients with moderate-to-severe psoriasis. METHODS: Cross-sectional, observational epidemiological study conducted in Spain and Portugal. Data were collected by 332 dermatologists for >or=10 consecutive presenting patients. RESULTS: Based on body surface area (BSA) and Psoriasis Area and Severity Index (PASI) criteria, moderate-to-severe psoriasis was confirmed in >or=79.3% of patients (n = 3,320). Preexisting comorbid conditions included psoriatic arthropathy (13%), dyslipidemia (14.1%) and hypertension (20.2%). The mean BSA involvement was 23% (95% confidence interval, CI: 22.2-23.3%), and the mean PASI score was 14.3 (95% CI: 13.9-14.6%). During the 2 years prior to assessment, 97.0% of patients had received topical treatments, whereas 31.3% had not received systemic treatment or phototherapy. The median annual cost of treatment was 825 EUR. CONCLUSION: Moderate-to-severe psoriasis is accurately diagnosed, but inadequately treated in many patients in Spain and Portugal.
No takes yet. Share an insight, caveat, or question.
García‐Diez et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: